Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Wagner, B; Melzer, H; Freymüller, G; Stumvoll, S; Rendi-Wagner, P; Paulke-Korinek, M; Repa, A; Mooi, FR; Kollaritsch, H; Mittermayer, H; Kessler, HH; Stanek, G; Steinborn, R; Duchêne, M; Wiedermann, U.
Genetic Variation of Bordetella pertussis in Austria.
PLoS One. 2015; 10(7):e0132623-e0132623 Doi: 10.1371/journal.pone.0132623 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Co-Autor*innen der Med Uni Graz
Kessler Harald
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
In Austria, vaccination coverage against Bordetella pertussis infections during infancy is estimated at around 90%. Within the last years, however, the number of pertussis cases has increased steadily, not only in children but also in adolescents and adults, indicating both insufficient herd immunity and vaccine coverage. Waning immunity in the host and/or adaptation of the bacterium to the immunised hosts could contribute to the observed re-emergence of pertussis. In this study we therefore addressed the genetic variability in B. pertussis strains from several Austrian cities. Between the years 2002 and 2008, 110 samples were collected from Vienna (n = 32), Linz (n = 63) and Graz (n = 15) by nasopharyngeal swabs. DNA was extracted from the swabs, and bacterial sequence polymorphisms were examined by MLVA (multiple-locus variable number of tandem repeat analysis) (n = 77), by PCR amplification and conventional Sanger sequencing of the polymorphic regions of the prn (pertactin) gene (n = 110), and by amplification refractory mutation system quantitative PCR (ARMS-qPCR) (n = 110) to directly address polymorphisms in the genes encoding two pertussis toxin subunits (ptxA and ptxB), a fimbrial adhesin (fimD), tracheal colonisation factor (tcfA), and the virulence sensor protein (bvgS). Finally, the ptxP promoter region was screened by ARMS-qPCR for the presence of the ptxP3 allele, which has been associated with elevated production of pertussis toxin. The MLVA analysis revealed the highest level of polymorphisms with an absence of MLVA Type 29, which is found outside Austria. Only Prn subtypes Prn1/7, Prn2 and Prn3 were found with a predominance of the non-vaccine type Prn2. The analysis of the ptxA, ptxB, fimD, tcfA and bvgS polymorphisms showed a genotype mixed between the vaccine strain Tohama I and a clinical isolate from 2006 (L517). The major part of the samples (93%) displayed the ptxP3 allele. The consequences for the vaccination strategy are discussed.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Adult -
Adult - epidemiology
Bacterial Proteins - genetics
Bacterial Proteins - metabolism
Bacterial Typing Techniques -
Base Sequence -
Bordetella pertussis - classification
Bordetella pertussis - genetics
Bordetella pertussis - immunology
Bordetella pertussis - pathogenicity
Child -
Child, Preschool -
DNA, Bacterial - genetics
DNA, Bacterial - immunology
DNA, Bacterial - isolation & purification
Female -
Fimbriae Proteins - genetics
Fimbriae Proteins - metabolism
Gene Expression -
Humans -
Immunization Programs - organization & administration
Infant -
Infant, Newborn -
Male -
Molecular Sequence Data -
Multilocus Sequence Typing -
Nasopharynx - immunology
Nasopharynx - microbiology
Pertussis Toxin - genetics
Pertussis Toxin - metabolism
Pertussis Vaccine - administration & dosage
Pertussis Vaccine - immunology
Polymorphism, Genetic -
Protein Subunits - genetics
Protein Subunits - metabolism
Transcription Factors - genetics
Transcription Factors - metabolism
Vaccination -
Virulence Factors, Bordetella - genetics
Virulence Factors, Bordetella - metabolism
Whooping Cough - epidemiology
Whooping Cough - immunology
Whooping Cough - microbiology
Whooping Cough - prevention & control

© Med Uni Graz Impressum